Pintarnya | $16,700,000 | (Aug 26, 2025)
Barti | $12,000,000 | (Aug 26, 2025)
Soil Action, Inc. | $5,250,000 | (Aug 26, 2025)
Certified by Founder
Lodge
Synnovation Therapeutics
start up
United States
- Wilmington, DE
- 18/01/2024
- Unknown
- $70,000,000
Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers.
We are dedicated to the discovery and development of first-in-class and best-in-class therapeutics that can improve the lives of people with cancer. Leveraging our deep expertise in medicinal chemistry, cancer biology and patient-focused precision medicine, we are building a diverse pipeline of novel small molecule targeted therapies. Our mission is to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.
- Industry Pharmaceutical Manufacturing
- Website https://www.synnovationtx.com/
- LinkedIn https://www.linkedin.com/company/synnovationtx/about/
Irys | $10,000,000 | (Aug 26, 2025)
Arintra | $21,000,000 | (Aug 26, 2025)
Oway | $4,000,000 | (Aug 26, 2025)
Paragraf | $55,000,000 | (Aug 26, 2025)
Genow | $1,921,342 | (Aug 26, 2025)
Luna Diabetes | $23,600,000 | (Aug 26, 2025)
Dirac, Inc. | $10,700,000 | (Aug 26, 2025)
STARK | $62,000,000 | (Aug 26, 2025)
Incyclix Bio | $11,250,000 | (Aug 26, 2025)